Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
about
Intestinal permeability defects: is it time to treat?The potential utility of tight junction regulation in celiac disease: focus on larazotide acetateBreaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disordersBrain-gut axis: from basic understanding to treatment of IBS and related disordersRelationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.Validating biomarkers of treatable mechanisms in irritable bowel syndromeClinical characteristics associated with postoperative intestinal epithelial barrier dysfunction in children with congenital heart disease.Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner.Drug development for the irritable bowel syndrome: current challenges and future perspectivesGastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.(13) C mannitol as a novel biomarker for measurement of intestinal permeabilityInteractions between zinc deficiency and environmental enteropathy in developing countries.Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.Complementary and alternative medicines in irritable bowel syndrome: an integrative view.Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.Intestinal barrier function in health and gastrointestinal disease.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Intestinal barrier: A gentlemen's agreement between microbiota and immunity.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Methods to determine intestinal permeability and bacterial translocation during liver disease.Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity.Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers.Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.Esophageal and Small Intestinal Mucosal Integrity in Eosinophilic Esophagitis and Response to an Elemental DietPsychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism.Increased subsequent risk of erectile dysfunction in patients with irritable bowel syndrome: a nationwide population-based cohort study.Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders.Differential trafficking of saccharidic probes following aspirin in clinical tests of intestinal permeability in young healthy women.The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability.
P2860
Q24629228-466319F5-6C88-486D-84DA-DEC6F14E7203Q26771888-21ACC7FC-165A-44A4-8DFE-2E49E27A27A0Q26777279-689966B5-4854-45EE-8652-0F9BB9B6FD51Q27024801-6A9961DA-5A2C-4A9E-B8EE-C22731A6FC4BQ33456815-8C12F17A-9F85-4C9E-BA92-86525149E221Q33717298-77B222ED-EA2B-4145-9767-2E57A4E9F754Q34131127-D6E58865-DB1C-4A5A-87E6-52E47A4352DBQ34324881-27D32968-4214-4591-8568-029958309B8DQ34577283-D9C1D848-4DB5-462B-935F-C55F9A27ECF5Q34859899-1205E6E3-B848-4AC6-9241-601410BD3EC6Q35118493-63607686-A090-44BC-B585-83E19DB94640Q35858688-CC6D3640-39B2-487B-898A-3CE5A8562412Q36494385-F65739C2-7945-49DB-857C-A9E983CD2539Q36573670-65C8EF68-F367-4941-A6D0-69BE214680FEQ36579818-2F5A0D2F-406D-4441-83F3-F6BCDA218A31Q36674027-7C56B6E6-A717-4BF3-9425-0D61B8838896Q36780412-5B8EDC54-6609-4339-A67C-10E21EE30720Q36970524-2F9ECDAD-A11B-4D88-9EBB-4273B6AD283BQ37037330-4F0DDC44-2493-4602-AC7B-6ACE06F13736Q37446572-27BFF0E0-32A2-4D99-A087-5CE79C6E625BQ37559869-5E6BF95D-73B3-4412-8D6C-236E8269E2E4Q37581337-92BBE76D-09C9-41ED-9803-FE08E1E680ABQ37698552-272C3BC9-6A12-4458-82CA-C991A49C8273Q37699665-FBB66072-B41C-46F6-BE28-A56A15F5A9F3Q38009940-F120E530-A536-434E-B505-CF264C23C9ACQ38016781-39947A02-EB09-4F4D-B23E-857134830A24Q38217233-B15B2CA4-DFEB-4919-9C86-414D91B108EBQ38275041-6D55905C-1CE9-4B98-AC0A-87F9220B9C83Q38321290-30CECFC6-746B-4AB1-A100-6D212C648B9FQ38749341-D6588B82-4CA2-43B2-8140-BBAC2C82D455Q38810529-84551694-B20E-42E5-A8DC-16DEF42EBB09Q39463126-CD70ADB0-1098-489B-AD95-6C21BFC8A07BQ40963516-475553B3-ED51-4A21-BD71-6ACC649BD79AQ41126753-03DC0532-E9D0-4A83-8323-CA85B9F2CFD1Q44572735-0746F378-A47E-4C9E-92D1-6AAF44295DDAQ45212489-3B1C12AE-6B7B-4DFA-948C-F9FEA935C609Q48270830-C168A03F-CEDB-4171-8C77-0BB214C7326AQ51204269-A52CB851-29BB-42CD-9C69-D241E36A9C04Q51327931-ACE6F4D4-2839-48E6-AFBE-C77621314B33
P2860
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@ast
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@en
type
label
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@ast
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@en
prefLabel
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@ast
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@en
P2093
P2860
P356
P1476
Urine sugars for in vivo gut p ...... yndrome-diarrhea and controls.
@en
P2093
Archana S Rao
Banny S Wong
Deborah J Eckert
Duane D Burton
Irene Busciglio
Jesse Lamsam
Michael Ryks
Ravinder Singh
P2860
P304
P356
10.1152/AJPGI.00168.2011
P577
2011-08-11T00:00:00Z